For: | Vincenzi F, Bizzarri B, Ghiselli A, de’ Angelis N, Fornaroli F, de’ Angelis GL. Cystic fibrosis and Crohn’s disease: Successful treatment and long term remission with infliximab. World J Gastroenterol 2010; 16(15): 1924-1927 [PMID: 20397273 DOI: 10.3748/wjg.v16.i15.1924] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i15/1924.htm |
Number | Citing Articles |
1 |
|
2 |
S. Visser, M. Martin, D. J. Serisier. Improvements in Cystic Fibrosis Lung Disease and Airway Inflammation Associated with Etanercept Therapy for Rheumatoid Arthritis: A Case Report. Lung 2012; 190(5): 579 doi: 10.1007/s00408-012-9393-9
|
3 |
Nazim Husain, Anoop Kumar, Arivarasu N. Anbazhagan, Ravinder K. Gill, Pradeep K. Dudeja. Intestinal luminal anion transporters and their interplay with gut microbiome and inflammation. American Journal of Physiology-Cell Physiology 2025; 328(5): C1455 doi: 10.1152/ajpcell.00026.2025
|
4 |
Elizabeth A. Clarke, Pippa Watson, Jane E. Freeston, Daniel G. Peckham, Andrew M. Jones, Alex Horsley. Assessing arthritis in the context of cystic fibrosis. Pediatric Pulmonology 2019; 54(6): 770 doi: 10.1002/ppul.24290
|
5 |
Premal Patel, Harvey R. Rabin, Michael M. Vickers, Michael D. Parkins. Metastatic Bladder Cancer Presenting with Persistent Hematuria in Young Man with Cystic Fibrosis. Case Reports in Pulmonology 2013; 2013: 1 doi: 10.1155/2013/831871
|
6 |
T Adelsten, N Rasmussen, TL Katzenstein, CT Nielsen. Safe and effective tumour necrosis factor-α inhibitor (etanercept) treatment of chronic episodic arthritis in a patient with cystic fibrosis. Scandinavian Journal of Rheumatology 2016; 45(4): 330 doi: 10.3109/03009742.2015.1122834
|
7 |
Chris J. Carter. Pathogen and autoantigen homologous regions within the cystic fibrosis transmembrane conductance regulator (CFTR) protein suggest an autoimmune treatable component of cystic fibrosis. FEMS Immunology & Medical Microbiology 2011; 62(2): 197 doi: 10.1111/j.1574-695X.2011.00803.x
|
8 |
Alan Peres, Fiona Flynn, Jorge Meira, Rachel Dunk, Susan Talbot, Susan Madge. Gastrointestinal issues in cystic fibrosis: a lifetime of disease. Gastrointestinal Nursing 2016; 14(5): 39 doi: 10.12968/gasn.2016.14.5.39
|
9 |
Dana-Teodora Anton-Păduraru, Alina Mariela Murgu, Laura Iulia Bozomitu, Dana Elena Mîndru, Codruța Olimpiada Iliescu Halițchi, Felicia Trofin, Carmen Iulia Ciongradi, Ioan Sârbu, Irina Mihaela Eṣanu, Alice Nicoleta Azoicăi. Diagnosis and Management of Gastrointestinal Manifestations in Children with Cystic Fibrosis. Diagnostics 2024; 14(2): 228 doi: 10.3390/diagnostics14020228
|
10 |
Robert C. De Lisle. Disrupted tight junctions in the small intestine of cystic fibrosis mice. Cell and Tissue Research 2014; 355(1): 131 doi: 10.1007/s00441-013-1734-3
|
11 |
Seth A. Reasoner, Irtiqa F. Fazili, Rachel Bernard, Jacob M. Parnell, Andrew G. Sokolow, Kelly F. Thomsen, Kathryn M. Edwards, Rebekah F. Brown, Maribeth R. Nicholson. Prevalence, Risk Factors, and Sequelae of Asymptomatic Clostridioides difficile Colonization in Children with Cystic Fibrosis. Journal of Cystic Fibrosis 2023; 22(5): 884 doi: 10.1016/j.jcf.2022.12.014
|
12 |
D.J. Gibson, C.G. Gallagher, G.A. Doherty. Infliximab is safe and induces sustained remission with complete mucosal healing in Crohn's disease in a patient with pan resistant pseudomonas cystic fibrosis: A case report. Journal of Crohn's and Colitis 2014; 8(11): 1561 doi: 10.1016/j.crohns.2014.04.011
|
13 |
Chiara De Cassan, Elisa Cinotti, Edoardo Savarino. An Unusual Cutaneous Manifestation in a Patient With Cystic Fibrosis. Gastroenterology 2014; 147(3): e10 doi: 10.1053/j.gastro.2014.04.055
|